AHC, initially described by Verret and Steele in 1971 [7], represents a rare neurodevelopmental disorder primarily caused by de novo ATP1A3 pathogenic variants [2, 8]. The gene discussed is ATP1A3; the disease is neurodevelopmental disorder.